Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. MDxHealth SA
  6. Company
    MDXH   BE0003844611

MDXHEALTH SA

(MDXH)
  Report
Real-time Euronext Bruxelles  -  11:35 2022-12-02 am EST
0.6430 EUR   -2.58%
11/29MDxHealth Provides Business Update
GL
11/29MDxHealth Provides Business Update
GL
11/29MDxHealth SA Provides Revenue Guidance for the Fiscal Year 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo MDxHealth SA
MDxHealth SA, leader in molecular diagnostics, is a company that develops and commercializes advanced epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The activity is organized around two product families:

- epigenetic molecular tests (ConfirmMDx): useful and innovative tests that allow researchers to correctly identify prostate cancer and treat it;

- non-invasive liquid biopsy tests (SelectMDx): tests that evaluate the risk of having aggressive prostate cancer during a biopsy.

Number of employees : 191 people.
Sales per Business
2021
Laboratory Services18.5698.6%
Licenses0.211.1%
Royalties and Other Revenues0.040.2%
EUR in Million
Sales per region
20202021Delta
United States15.5896.2%18.4398% +18.3%
Netherlands0.311.9%0.160.9% -46.57%
Spain0.120.7%0.090.5% -19.63%
Rest of European Union0.100.6%0.060.3% -38%
Belgium0.030.2%0.020.1% -13.53%
Poland0.010.1%0.020.1% +38.64%
Italy0.030.2%0.010.1% -61.93%
Rest of the World0.020.1%0.010.1% -40.3%
EUR in Million
Managers
Name Title Age Since
Michael K. McGarrity Chief Executive Officer & Executive Director 58 2019
Ron Kalfus Chief Financial Officer 46 2019
Miriam Reyes Executive Vice President-Operations - -
Joseph Sollee Chief Compliance Officer, EVP & General Counsel 57 -
John Bellano Chief Commercial Officer 52 2019
Harry Rentrop Sales Director-Benelux-SelectMDx - -
Members of the board
Name Title Age Since
Koen Hoffman Chairman 53 2018
Lieve Verplancke, Dr. Independent Non-Executive Director 61 2017
Hilde Windels Independent Non-Executive Director 55 2017
Regine Slagmulder, Dr. Independent Non-Executive Director 54 2020
Donnie M. Hardison Independent Non-Executive Director 70 2021
Jan Mark Angele Pensaert Non-Independent Non-Executive Director 50 -
Michael K. McGarrity Chief Executive Officer & Executive Director 58 2019
Eric Bednarski, Dr. Non-Independent Non-Executive Director 49 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 162,880,936 137,273,959 84.3% 0 0.0% 84.3%
Shareholders
NameEquities%
MVM Partners LLP 35,504,584 21.8%
Valiance Asset Management Ltd. 19,028,245 11.7%
Rudi M. MariŰn 11,008,257 6.76%
BNP Paribas Asset Management Belgium SA 1,535,710 0.94%
Perinvest (UK) Ltd. 220,000 0.14%
Dimensional Fund Advisors LP 118,590 0.073%
Dimensional Fund Advisors Ltd. 19,396 0.012%
Perkins Capital Management, Inc. 11,000 0.0068%
Markets and indexes
- Compartiment B
- BEL Small / Next Biotech, PEA, Tech 40
Stock Exchange Codes
- Bloomberg Code :  ONCOB:BB
- Reuters Code :  ONCOB.BR
- Datastream Code :  
Company contact information
MDxHealth SA
CAP Business Center Rue d'Abhooz 31
BE-4040 Herstal, LiŔge

Phone : +32 (0)4 364 20 70
Fax : +32 (0)4 259 78 75
web site : https://mdxhealth.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of MDxHealth SA
Sector Other Biotechnology & Medical Research